Arvinas, Inc.

US$6.41As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ARVNHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (11.25%)
Div yield —
ROE (1.76%)
Biotechnology
Beta (5Y) 1.80
PE TTM —
TSR TTM (36.79%)
Mkt cap US$419.8M
ROIC (3.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.29
13.72%
(77.53%)
Hold 8|11|6|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.08
11.13%
5.52%
3.27%
17.29%
Revenue$M
28.88
29.80
30.78
31.34
(0.90%)
5.32%
10.72%
10.71%
Peers (US$419.8M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.476
0.499
0.448
EBIT/Intx
0.075
0.467
0.347
Own earn%
(47.87)
(79.19)
(108.40)
Sh yield%
27.63
63.05
61.90
Owners
Insiders/Inst%
14.51
59.43
Short interest%
3.67
SBC / revenue%
5.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–17
$1 testx
10.1
Incr. ROIC%
8